Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

510
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
510
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.3K
2.3K
Allosteric Regulation01:08

Allosteric Regulation

57.6K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

5.7K
Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TME/NIR Dual-Responsive Zinc-Based Targeted Nanoagonist for Multimodal Amplification of STING-Mediated Cancer Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR.

Journal of medicinal chemistry·2026
Same author

Virtual reality in physiological education: Influence of learning modality and learner characteristics on learning outcomes.

Acta psychologica·2026
Same author

High viscosity microenvironment induces chemoresistance of cancer cells through upregulating P-gp.

International journal of pharmaceutics·2026
Same author

Fractional-Order Dynamics Learning and Control via Data-Driven Approaches: Taking Soft Manipulator as an Example.

IEEE transactions on neural networks and learning systems·2026
Same author

Unlocking Multiscale Allosteric Mechanisms: Advanced Computational Strategies for Drug Discovery.

Medicinal research reviews·2026
Same journal

Metabolic disruptions through a three-dimensional genomic lens.

Current opinion in structural biology·2026
Same journal

Collective variable design for biomolecular conformational dynamics.

Current opinion in structural biology·2026
Same journal

Polymer scaling in protein crowding: From dilute coils to semidilute meshes.

Current opinion in structural biology·2026
Same journal

Tuning the physicochemical properties of rationally designed protein-based biomolecular condensates.

Current opinion in structural biology·2026
Same journal

Editorial overview: Folding, binding and protein design.

Current opinion in structural biology·2026
Same journal

Macromolecular crowding reshapes the conformational landscapes of intrinsically disordered proteins: mechanisms, cellular contexts, and functional consequences.

Current opinion in structural biology·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2025

Author Spotlight: Advancing Protein Structure Analysis for Drug Development
07:08

Author Spotlight: Advancing Protein Structure Analysis for Drug Development

Published on: March 8, 2024

3.4K

Advances in structure-based allosteric drug design.

Rui Li1, Xinheng He2, Chengwei Wu2

  • 1State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Current Opinion in Structural Biology
|December 30, 2024
PubMed
Summary
This summary is machine-generated.

This review enhances allosteric drug discovery by integrating structural and computational biology. It uses case studies and AI to improve understanding of allosteric mechanisms and identify binding sites.

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.0K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Related Experiment Videos

Last Updated: Jun 4, 2025

Author Spotlight: Advancing Protein Structure Analysis for Drug Development
07:08

Author Spotlight: Advancing Protein Structure Analysis for Drug Development

Published on: March 8, 2024

3.4K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.0K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Computational Biology

Background:

  • Allosteric drug discovery is crucial but hindered by high failure rates in current screening methods.
  • Limited understanding of allosteric mechanisms contributes to the inefficiency of traditional drug development strategies.

Purpose of the Study:

  • To enhance comprehension of allosteric mechanisms through case studies, structural databases, and computational algorithm development.
  • To guide more effective allosteric drug development by integrating structural and computational biology insights.

Main Methods:

  • Review of case studies on allosteric mechanisms.
  • Analysis of protein structure databases.
  • Examination of computational algorithm developments in allostery.

Main Results:

  • Integration of structural and computational biology is vital for translating 3D structural data into drug discovery knowledge.
  • AI algorithms and structural datasets are key for identifying allosteric binding sites and establishing structure-activity relationships (SARs).

Conclusions:

  • Advancements in computational algorithms tailored for allosteric proteins are driving the field forward.
  • Improved understanding of allostery through integrated approaches promises more effective allosteric drug discovery.